271651

NCT00118638
Completed

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

Conditions: Anemia; Non-Myeloid Malignancies

April 25, 2013

271652

NCT00118625
Completed

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Conditions: Type I Hypersensitivity

June 16, 2010

271653

NCT00118612
Completed

Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen

Conditions: Type I Hypersensitivity

June 16, 2010

271654

NCT00118586
Active, not recruiting

Neuropathology of Spasmodic Dysphonia

Conditions: Voice Disorders

August 8, 2018

271655

NCT00118573
Terminated

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

Conditions: Aortic Aneurysm, Abdominal; Endovascular

December 9, 2015

271656

NCT00118560
Completed

Exercise Training for Patients With Poor Leg Circulation

Conditions: Diabetes Mellitus, Type 2; Intermittent Claudication

March 16, 2011

271657

NCT00118547
Completed

Health Behavior Change in Chronic Disease Management

Conditions: Multiple Sclerosis

August 11, 2011

271658

NCT00118534
Completed

Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder

Conditions: Mental Health; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Tobacco Use Disorder

April 18, 2014

271659

NCT00118521
Completed

A Clinical Study in the Use of Orthotics in Treating Pain in the Front of the Knee

Conditions: Patellofemoral Pain Syndrome

December 18, 2013

271660

NCT00118508
Completed

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Conditions: Osteoporosis

August 10, 2015

271661

NCT00118495
Completed

Zestra in Women With Mixed Sexual Dysfunction

Conditions: Sexual Dysfunction, Psychological

July 4, 2007

271662

NCT00118482
Completed

Clinical Trial for the Prevention of Vasovagal Syncope

Conditions: Syncope, Vasovagal, Neurally-Mediated

May 25, 2017

271663

NCT00118469
Unknown status

Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents With Depression

Conditions: Depression

April 1, 2008

271664

NCT00118456
Completed

Study of Oral AEE788 in Adults With Advanced Cancer

Conditions: Cancer

January 5, 2012

271665

NCT00118443
Completed

Evaluation of a School-Based Training Program for Suicide Prevention

Conditions: Suicide

June 27, 2013

271666

NCT00118430
Completed

Stepped Care for Depression and Musculoskeletal Pain

Conditions: Pain; Depression

March 28, 2017

271667

NCT00118417
Completed

Therapies for Treatment-Resistant Panic Disorder Symptoms

Conditions: Panic Disorder

June 5, 2014

271668

NCT00118404
Completed

Cognitive Therapy for Recurrent Depression

Conditions: Depression

May 13, 2014

271669

NCT00118391
Completed

Cognitive-Behavioral Treatment of Gambling

Conditions: Gambling; Mental Health

June 28, 2013

271670

NCT00118378
Completed

Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS

Conditions: HIV Infections; Fatigue

April 3, 2017

271671

NCT00118365
Completed

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

Conditions: Precancerous Condition

January 12, 2015

271672

NCT00118352
Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Conditions: Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia

April 25, 2017

271673

NCT00118339
Completed

Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma

Conditions: Multiple Myeloma; Plasma Cell Neoplasm

August 30, 2011

271674

NCT00118326
Completed

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Conditions: Kidney Cancer; Leukemia; Lymphoma; Myelodysplastic Syndromes; Neuroblastoma; Sarcoma

May 12, 2010

271675

NCT00118313
Completed

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Conditions: Melanoma (Skin)

December 18, 2014

271676

NCT00118300
Withdrawn

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Conditions: Cervical Cancer; Endometrial Cancer; Ovarian Cancer; Vaginal Cancer

July 7, 2011

271677

NCT00118287
Completed

Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes

Conditions: de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes

April 17, 2017

271678

NCT00118274
Completed

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Conditions: Melanoma (Skin)

August 31, 2017

271679

NCT00118261
Completed

Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer

Conditions: Colorectal Cancer

August 31, 2012

271680

NCT00118248
Completed

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Conditions: Recurrent Thyroid Cancer; Stage IV Follicular Thyroid Cancer; Stage IV Papillary Thyroid Cancer; Thyroid Gland Medullary Carcinoma

December 28, 2016

271681

NCT00118235
Completed

Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Conditions: Extensive Stage Small Cell Lung Cancer

June 16, 2014

271682

NCT00118222
Completed

High Light and Low Light Dose PDT in Glioma

Conditions: Brain and Central Nervous System Tumors

June 9, 2010

271683

NCT00118209
Active, not recruiting

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Conditions: Large B Cell Lymphoma

July 9, 2018

271684

NCT00118196
Terminated

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Conditions: Leukemia; Myelodysplastic Syndromes

May 7, 2018

271685

NCT00118183
Completed

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Conditions: Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Large Cell Lung Cancer; Malignant Pleural Effusion; Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer

June 3, 2013

271686

NCT00118170
Completed

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Splenic Marginal Zone Lymphoma; Stage II Multiple Myeloma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia

January 4, 2013

271687

NCT00118157
Completed

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

Conditions: Estrogen Receptor Positive; Male Breast Carcinoma; Progesterone Receptor Positive; Recurrent Breast Carcinoma; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer

October 27, 2017

271688

NCT00118144
Completed

Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer

Conditions: Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer

August 4, 2014

271689

NCT00118131
Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Conditions: Lung Cancer

September 19, 2013

271690

NCT00118105
Withdrawn

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

Conditions: Colorectal Cancer; Metastatic Cancer

January 2, 2013

271691

NCT00118092
Completed

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage IV Prostate Cancer

March 20, 2017

271692

NCT00118066
Terminated

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Conditions: Precancerous/Nonmalignant Condition; Prostate Cancer

May 22, 2015

271693

NCT00118053
Terminated

Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer

Conditions: Breast Cancer

September 17, 2013

271694

NCT00118040
Completed

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Conditions: Recurrent Bladder Cancer; Stage I Bladder Cancer; Stage II Bladder Cancer; Stage III Bladder Cancer

May 23, 2017

271695

NCT00118027
Completed

A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda

Conditions: Malaria; Pregnancy; Anemia

January 11, 2017

271696

NCT00118014
Completed

Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania

Conditions: Impulse Control Disorders

May 19, 2008

271697

NCT00118001
Completed

Psychotherapy of Generalized Anxiety Disorder

Conditions: Anxiety Disorders

March 31, 2015

271698

NCT00117988
Completed

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Conditions: Anaplastic Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma

May 21, 2014

271699

NCT00117975
Completed

Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Conditions: Lymphoma

July 1, 2016

271700

NCT00117962
Completed

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Conditions: Lung Cancer

August 29, 2016